The aim of this study was to establish the discriminating accuracy of Kanao's pre-operative nomogram for renal cell carcinoma in predicting cause-specific survival among representative patients who underwent nephrectomy. Patients originated from two centers: Chiba University Hospital (n ¼ 151) and Chiba Cancer Center (n ¼ 91). We validated the predictive accuracy, which was assessed using Harrell's concordance-index. The concordance-index values were 0.692 and 0.834 for Chiba University Hospital and Chiba Cancer Center, respectively, although it was 0.822 for the combined data sets. Results of external validation were different at each cohort. We constructed calibration plots of Kanao's nomogram and confirmed the tendency at each institution. Inconsistency of results among two centers makes it difficult to reach a valid conclusion. Therefore, the predictive accuracy of Kanao's nomogram was not settled. Clinicians need to confirm the predictive accuracy of Kanao's nomogram and construct calibration plots when applying this nomogram to different patient populations.
INTRODUCTION
Renal cell carcinoma (RCC) is the most frequent malignancy of the adult kidney, with 30 000 new cases expected per year in the USA and 20 000 cases expected in the European Union (1). The incidence of RCC has increased by 30% in the last 20 years (2) . Although the incidence of RCC in Japan is lower than in other developed countries, it has been increasing in recent years (3) . In 1997, the incidence rates (persons per 100 000) in Japan were 7.1 for men and 3.1 women; rates in 2002 were 8.2 for men and 3.6 for women (4, 5) .
The rapidly increasing incidence of RCC may be partly explained by new imaging techniques and improvements in diagnosis (3) . Although the largest rise has been observed among small tumors, the incidence of large tumors and the overall mortality has continued to increase as well (6, 7) . Although a significant downward stage migration has occurred in recent years, up to 30% of patients present with advanced disease at diagnosis (6, 8) . The prognosis of advanced RCC is still poor, and reliable prognostic indicators that distinguish between patients with different prognoses are needed to predict outcomes and help choose treatments and follow-up methods (9 -10) .
Nephrectomy is now accepted as first-line treatment for localized RCC (11) . A recent study concluded that in patients with metastatic RCC, nephrectomy also improved their survival if patients presented with good performance status (12) . Therefore, accurate pre-operative staging that identified the extent of the tumor and metastasis at the time of its primary diagnosis is mandatory for surgical planning and assessing prognosis (13) .
A pre-operative prediction of patients' survival, including patients with metastatic RCC, may be helpful for clinicians and patients discussing treatment options or obtaining informed consent to undergo treatment (11) . Survival is the most important indicator for assessing the clinical outcome in patients who undergo surgical treatment (11).
Kanao et al. (11) developed a pre-operative prognostic nomogram based on only TNM classification to predict cause-specific survival in patients, including those with metastatic RCC, because a pre-operative prognostic nomogram that predicts survival in patients with RCC was not available then. Kanao's nomogram was found to have excellent ability to discriminate using bootstrapping, as evidence by Harrell's concordance-index (c-index) of 0.81 (11) . However, it was only validated internally. The generalization of Kanao's nomogram to external cohorts of patients with characteristics different from the original data set has yet to be validated. Kanao et al. (11) also mentioned that it is necessary to perform external validation to estimate the accuracy of their nomogram at different institutions and in other populations.
The aim of this study was to establish the discriminating accuracy of Kanao's nomogram in predicting cause-specific survival among representative patients who underwent nephrectomy in two centers.
PATIENTS AND METHODS

STUDY POPULATION
All subjects were Japanese patients who underwent partial or radical nephrectomy for RCC between 1990 and 2005. Patients originated from two centers: Chiba University Hospital (CUH, n ¼ 151) and Chiba Cancer Center (CCC, n ¼ 91), Chiba, Japan. Cases were staged with computed tomography (CT) of the abdomen and pelvis, chest CT or chest X-ray before nephrectomy. If necessary, magnetic resonance imaging (MRI) was used to improve pre-operative staging. Advanced disease was generally treated with interferon-a-or recombinant interleukin-2-based immunotherapy regimens after nephrectomy. From 1990 to 2005, the treatment criteria and modalities for each stage were similar to each other between two centers. They did not basically change between 1990 and 2005, before the moleculartargeted therapy era.
Patient management and follow-up procedures were performed in accordance with the protocols of each institution. Medical records were surveyed retrospectively and the following data were collected from patient charts: age, gender, clinical presentation (incidental, local and systemic), surgical technique, 2002 TNM classification, clinical tumor size as the greatest diameter in centimeters, disease recurrence and progression. Patients were staged according to the 2002 staging system of the Union International Contre le Cancer and the American Joint Committee on Cancer (14) . Patient characteristics at each institution, as well as those from the original cohort from Kanao et al. (11) are shown in Table 1 . 
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Validation study of renal cell carcinoma NOMOGRAM Kanao's nomogram was originally developed and validated to predict 1-, 3-and 5-year cause-specific survival (11) . However, the nomogram was used to calculate the probability of cause-specific survival after 5 years of follow-up in this study, because cause-specific survival rate after 5 years is generally used in clinical practice.
STATISTICAL ANALYSIS
A total of 151 patients in CUH and 91 patients in CCC with baseline and follow-up data were available for analysis. Kanao's nomogram was externally validated in these two cohorts. To validate the nomogram externally, the c-index was estimated to calculate an unbiased measure of the ability of the nomogram to discriminate among patients (15) . The 95% confidence interval (95% CI) of the c-index value was calculated by bootstrapping. Moreover, we constructed the calibration plots of Kanao's nomogram, in which the x-axis represents the predicted probability of cause-specific survival after 5 years and the y-axis represents the actual probability of that. All analyses were performed using R software (http://www.r-project.org/). All calculated P values were two-sided and P , 0.05 was considered statistically significant.
RESULTS
The c-index values describing the predictive accuracy of the nomogram were 0.692 (95% CI, 0.489 -0.895) in CUH and 0.834 (95% CI, 0.773 -0.895) in CCC, whereas it was 0.822 (95% CI, 0.756 -0.889) in the combine data sets. The c-index value of Kanao's nomogram in CCC was much higher than that in CHU. Although these c-index results were compared using t-tests, differences were not statistically significant (P ¼ 0.191). Figure 1 shows the calibration plot of Kanao's nomogram in CUH, CCC and the combined data sets. As a whole, the calibration plot of Kanao's nomogram in CUH gave an overestimation of the predicted probability of cause-specific survival after 5 years when compared with the actual probability. The calibration plot in CCC and the combined data sets demonstrated that the predicted probability of cause-specific survival after 5 years is consistent with the actual probability.
DISCUSSION
Nomograms are the most accurate paper-based method for explaining predicted probabilities to patients (16, 17) . However, in our study, Kanao's nomogram showed poor performance (c-index ,0.700) in predicting cause-specific survival after 5 years in the CUH population, although patient characteristics between the CUH population and Kanao's original population were similar. On the other hand, the nomogram demonstrated good performance (c-index 0.834) in the CCC population, although the characteristics between the CCC population and Kanao's original population were not similar. Moreover, Kanao's treatment of advanced disease using interferon-a-or recombinant interleukin-2-based immunotherapy regimens after nephrectomy is similar to ours. Several nomograms have already been validated using different data sets from other institutions or populations (17 -19) . External validation was generally performed using a large data set at a single center or combined data sets at multiple institutions (17 -19) . Each of our populations was smaller than one used by Kanao et al. to derive their model (n ¼ 545 versus 151 in CUH or 91 in CCC). However, nomograms need to be applicable to different populations (20) .
In previous studies, pre-operative models substantially worse than post-operative models (18, 19) . Furthermore, higher accuracy in outcome prediction can be achieved using integrated systems that combine multiple independent prognostic variables (21) . Although only pre-operative 2002 TNM classification was incorporated into Kanao's nomogram, this simple application made this nomogram easily available at any institution. This availability is one advantage of this nomogram over others.
TNM stage is the strongest independent prognostic factor for RCC (21) . Both multidetector-row CT and MRI performed highly in T staging of local tumor extent and M staging of distant metastasis but performed poorly in N staging (13) . Unless metastasis of the lymph node was suspected on pre-operative radiographic assessment, lymph node dissection was not routinely performed. It is likely that poor performance in N staging influences the predictive accuracy of any model in which TNM classification was incorporated into the model.
The seventh edition of the TNM was recently released that includes modifications for the staging system of kidney cancers (22) . It was validated externally and confirmed to be a powerful predictor of cancer-specific survival in patients with RCC (22) . In the near future, a new model should be constantly upgraded and derived from a multitude of data sets as new prognostic factors and improved modeling techniques become available (17, 23, 24 ).
Kanao's nomogram was developed based on a Japanese population (11) . In this study, external validation was performed using Japanese data sets. An external validation of Kattan's nomogram in a French population showed a lower prognostic accuracy for RCC recurrence with a c-index value of 0.607 (95% CI, 0.576 -0.635) (17) . On the other hand, better prognostic accuracy for RCC recurrence was shown in a Chinese population, with a c-index value of 0.841 (95% CI, 0.802 -0.879) (19) . In view of these results, combined with ours, ethnicity may be not an important factor when using a nomogram. Moreover, a prognostic model needs to be validated externally to confirm the predicting and discriminating accuracy in each population (17) (18) (19) .
In previous validation studies, only discrimination, and not calibration accuracy, was assessed (17 -19) . However, we need the calibration plot to understand the difference between the predicted probability and the actual probability. In our study, the predicted prognosis for 5-year causespecific survival calculated by Kanao's nomogram was better than outcomes actually observed in CUH patients, using constructed calibration plots of the nomogram, whereas it was found to be consistent with actual outcomes observed in CCC patients. These findings highlight that caution need to be exercised when routinely applying the nomogram to different populations.
To our knowledge, this is the first article to validate Kanao's nomogram externally. The results of external validation were different at each institution, although we could not find the difference using the combined data sets only. Inconsistency of these results among the two centers makes is difficult to draw a valid conclusion. Therefore, the predictive accuracy of Kanao's nomogram is still not settled.
Certainly, there are some potential limitations of our study. Our study did not include any patients with T3c and T4. Therefore, these patients were not fully validated in this study. Moreover, the number of the patients at CCC, as a single institution, might be smaller to validate Kanao's nomogram. We need to conduct a further investigation in view of these limitations to draw a definitive conclusion about predictability of Kanao's nomogram.
Kanao's nomogram is presented as probability tables because TNM factors were simple nominal variables and it can directly express cause-specific survival (11) . A preoperative nomogram similar to Kanao's nomogram may be not needed, because we can easily use Kanao's nomogram. Outcome prediction models can be used to counsel patients, determine the need for adjuvant therapy, stratify patients for clinical trials and develop appropriate post-operative surveillance programs tailored to the risk of cancer progression. If possible, clinicians should confirm the predictive accuracy of Kanao's nomogram and construct a calibration plot to understand tendencies when applied to different patient populations.
